ImmuneBridge Funding & Investors
San Francisco, CA
ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural ki... Read more
immunebridge.comTotal Amount Raised: $17,632,000
ImmuneBridge's Investors
ImmuneBridge Funding Rounds
Series Unknown
$5,632,000
Seed
$12,000,000
Seed Investors
Insight Venture PartnersM VenturesOne Way VenturesGaingels
Funding info provided by Diffbot.